Mybiosource
PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) Mouse Monoclonal Antibody [Clone PDL1/2746]
- SKU:
- MBS4380524
- Availability:
- Next week
Description
PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) Mouse Monoclonal Antibody [Clone PDL1/2746] is available at Gentaur for Next Week Delivery.
Product Short Name: PD-L1 / PDCD1LG1 / CD274 / B7-H1
Other Names:
Product Gene Name: [CD274]
Other Gene Names:
Clonality:
Isotype: IgG2b, kappa
Clone:
Host: Mouse
Reactivity: Human, Mouse
Specifity: Engagement of CD28 by B7-1 (CD80) or B7-2 (CD86) in the presence of antigen promotes T-cell proliferation, cytokine production, differentiation of effector T-cells and the induction of BCLX, a promoter of T-cell survival. recruitment of CTLA4 by B7-1 or B7-2, on the other hand, may inhibit proliferation and interleukin-2 (IL-2) production. PD-L1 is 290-amino acid type I transmembrane protein, which is 20% and 15% identical to B7-1 and B7-2, respectively, has immunoglobulin V-like and C-like domains and a 30-amino acid cytoplasmic tail. PD-L1 does not bind CD28, cytotoxic T-lymphocyte A4 or ICOS (inducible co-stimulator). IL-2, although produced in small amounts, is required for the effect of PD-L1 co-stimulation. PD-L2 protein contains a signal sequence, IgV- and IgC-like domains, a transmembrane region and a cytoplasmic region. Constitutive expression of PD-L1 and PD-L2 on parenchymal cells of heart, lung and kidney suggests that the PD-1-PD-L system could provide unique negative signaling to help prevent autoimmune diseases.
Purity:
Form: 200ug/ml of Ab purified from Bioreactor Concentrate by Protein A/G. Prepared in 10mM PBS with 0.05% BSA & 0.05% azide. Also available WITHOUT BSA & azide at 1.0mg/ml.
Concentration:
Storage Stability: Antibody with azide - store at 2 to 8 degree C. Antibody without azide - store at -20 to -80 degree C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.
Tested Application: